[The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma]. 1997

K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
Department of Urology, School of Medicine, University of Tokushima.

OBJECTIVE The correlation between the serum soluble interleukin-2 receptor (SIL-2R) levels and clinical stage is demonstrable in a variety of non-Hodgkin lymphomas. The prognostic significance of sIL-2R levels in the serum of patients with renal cell carcinoma (RCC) was investigated. METHODS sIL-2R were measured in patients with RCC (n=39) and normal control (n=6) by the enzyme immunoassay technique. Cases of RCC were classified according to the clinical stage, pathological grade and growth type. The IL-2R expression of RCC was evaluated by RT-PCR. RESULTS The serum sIL-2R levels of patients with RCC showed significantly higher values than those of controls (p < 0.05). The serum sIL-2R levels in RCC were closely associated with the stage, grade and growth type of disease. The patients with high serum sIL-2R level (> = 1,000 U/L) exhibited a significantly poorer prognosis than those with low serum sIL-2R level (<1,000 U/L). The band of IL-R was detected only by using the template from the mRNA extracted from a resected tumor tissue of the RCC but not from the RCC cell lines. CONCLUSIONS It was suggested that the measurement of serum sIL-2R levels is useful for predicting the prognosis.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
January 2004, Clinical transplantation,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
January 1993, Zhonghua zhong liu za zhi [Chinese journal of oncology],
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
December 1994, Journal of endocrinological investigation,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
January 2004, Annals of clinical and laboratory science,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
April 1992, Bollettino della Societa italiana di biologia sperimentale,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
January 2004, Roczniki Akademii Medycznej w Bialymstoku (1995),
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
January 1990, Zeitschrift fur Rheumatologie,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
June 1996, Rinsho byori. The Japanese journal of clinical pathology,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
February 1995, Clinical transplantation,
K Akiyama, and M Tsuji, and Y Kurokawa, and K Yokota, and K Kojima, and S Naruo, and H O Kanayana, and S Kagawa
August 1990, Transplantation proceedings,
Copied contents to your clipboard!